Objectives: To determine the ef®cacy of oral iodized oil in goitrous children who are both selenium (Se) and iodine de®cient; to investigate if Se status modi®es the response of iodine de®cient, goitrous children to oral supplementation with iodized oil. Design: A longitudinal intervention trial. Setting: Two rural villages in the western Co Ãte d'Ivoire. Subjects: 51 goitrous non-anemic schoolchildren with both iodine and Se de®ciency. Intervention: Each child received an oral dose of 0.4 ml iodized poppyseed oil containing 200 mg of iodine. They were followed for 1 y with measurements of urinary iodine (UI), thyrotropin (TSH), thyroxine (T4), and thyroid volume by ultrasound. Results: At baseline all children were goitrous and Se de®cient; median UI was 29 mgal and mean serum Se (s.d.) was 14.8 (10.7) mgal. After receiving iodized oil, thyroid volume decreased signi®cantly vs baseline at 10, 15, 30 and 50 weeks (P`0.001). At 50 weeks mean percentage change in thyroid volume from baseline was746.6% and only ®ve children remained goitrous. Median TSH values at 5, 10, 15, 30 and 50 weeks were reduced signi®cantly (P`0.001) compared to baseline. Among individual children the severity of Se de®ciency predicted the degree of response to iodized oil. Baseline serum Se and percentage change in thyroid volume from baseline at 50 weeks were strongly correlated (r 2 0.554). Baseline Se and percentage decrease in TSH from baseline at 30 weeks were also well-correlated (r 2 0.467). Conclusion: Although more severe Se de®ciency partially blunts the thyroid response to iodine supplementation, oral iodized oil is an effective method for iodine repletion in goitrous children who are Se de®cient.
Introduction
Iodine de®ciency produces a spectrum of disorders Ð endemic goiter, hypothyroidism, cretinism and congenital anomalies Ð that are termed the iodine de®ciency disorders (IDD; WHOaUNICEFaICCIDD, 1994) . Mild iodine de®-ciency also impairs intellectual development and can reduce average population cognitive scores by 10 ± 15% (Maberley, 1998) . In Western and Central Africa, it is estimated that 250 million people are at risk for IDD and 50 million have goiter (Bailey & Clugston, 1990) .
Multiple nutritional and environmental in¯uences contribute to the prevalence and severity of IDD in iodinede®cient areas (Gaitan, 1990; Boyages, 1993) . Se is an essential component of the iodothyronine 5 0 -deiodinases, which convert thyroxin (T 4 ) to the more biologically active 3,5,3 0 -triiodothyronine (T 3 ) (Arthur et al, 1999) . Glutathione peroxidase (GPX), another Se-containing enzyme, is an important antioxidant in the thyroid gland. In animals, Se de®ciency can lower deiodinase activity and adversely affect thyroid metabolism (Beech et al, 1995; Beckett et al, 1991) . In humans, cross-sectional studies have suggested that poor Se nutrition may be associated with impaired thyroid metabolism in iodine-de®cient populations (Vanderpas et al, 1990; Thilly et al, 1993) . There are no published data describing the use of oral iodized oil to treat iodine de®ciency in children who are both iodine and Se de®cient. Also, there have been no published prospective studies describing the in¯uence of Se status on the response to iodine supplementation in iodine de®-cient populations.
Severe de®ciencies of Se and iodine coexist in China, Southeast Asia, Russia, Egypt and Central Africa (Utiger, 1998) . In these regions, interactions between Se and iodine de®ciency may be important determinants of patterns of disease. In Tibet, where severe Se de®ciency is endemic, iodine de®ciency is a risk factor for Kashin ± Beck disease (Moreno-Reyes et al, 1998) . In rural Zaire, combined iodine and Se de®ciency is associated with increased risk for endemic myxoedematous cretinism (Vanderpas et al, 1990) .
In the mountainous western regions of the Co Ãte d'Ivoire, Se de®ciency is common and the prevalence of goiter among school age children approaches 50% (Ministry of Health, 1994) . Therefore, the aims of this study were: (a) to determine the ef®cacy and safety of oral iodized oil in goitrous children who are both Se and iodine de®cient; and (b) to investigate if Se status modi®ed the response of iodine-de®cient, goitrous children to oral supplementation with iodized oil.
Methods
The study was carried out in two isolated villages (total population 1450) in an area of endemic goiter in the mountains of the western Co Ãte d'Ivoire (Latapie et al, 1981) . The villages are 5 km apart and are similar ethnically. The staple foods are rice and cassava. The study was approved by the Ethical Review Board of the University Hospital of Zu Èrich, the National Institute of Public Health and the Ministry of Research of the Co Ãte d'Ivoire. Oral informed consent was obtained from the chiefs of the villages and the families of the subjects.
All children aged 6 ± 15 y in the two villages (n 419) were screened. Weight and height were measured and goiter was graded using WHO criteria (WHOa UNCFaICCIDD, 1994) . Spot urine samples were collected for measurement of Urinary Iodine (UI). Blood was collected by venipuncture for determination of hemoglobin (Hb) and spotted onto ®lter paper for measurement of whole blood TSH and serum T 4 . The complete results of the screening have been described previously (Zimmermann et al, 2000) .
All 6 ± 12 year old children with Grade 1 goiter and who were not anemic (Hb b 120 gal) were invited to join an intervention study with oral iodized oil. After a brief physical examination, 53 children were enrolled. Baseline measurements in the morning before administration of the iodized oil included iodine in spot urines, TSH and serum T 4 on blood spotted onto ®lter paper, serum retinol and serum Se. Thyroid gland volume was measured using an Aloka SSD-500 Echocamera (Aloka, Mure, Japan) with a high-resolution 7.5 MHz linear transducer (DeLange et al, 1997) .
Each child then received an oral dose of 0.4 ml iodized poppyseed oil (Lipiodol, Guerbet, France) containing 200 mg of iodine. At 1, 5, 10, 15, 30 and 50 weeks postintervention, spot urines were collected for measurement of UI and dried blood spots for determination of TSA and T 4 . At 10, 15, 30 and 50 weeks, thyroid volume was measured using ultrasound. To avoid interobserver variability, all ultrasound measurements were performed by a single investigator (MBZ). At 15 weeks, spot urines were collected for measurement of urinary thiocyanate. At 10, 15, 30 and 50 weeks height and weight were remeasured to account for the potential affect of growth on thyroid volume. Of the 53 children who began the study, 51 completed it.
In countries with a high prevalence of child growth retardation, thyroid volume is considered to be more directly a function of total body surface area (BSA) than of age. Therefore, BSA was calculated from weight and height measurements taken with each ultrasound measurement, and normative values for thyroid volume in children aged 6 ± 12 y according to sex, age and BSA were used to de®ne the presence or absence of goiter (WHOaICCIDD, 1997) .
Blood and urine samples were aliquoted and frozen at 720 C until analysis. UI was measured using a modi®ca-tion of the Sandell ± Kolthoff reaction (Pino et al, 1996) . Serum Se was measured by atomic absorption spectrometry with the Zeeman background correction (Perkin-Elmer Model 4100 ZL, Norwalk, CT) with a limit of sensitivity of 6.5mgal; undetectable concentrations were assigned a value of 6.5mg Seal (Van Dael et al, 1995) . Serum retinol was measured by HPLC (Catignani & Bieri, 1983) . Hb was measured using the cyanmethemoglobin method with kits (Sigma Diagnostics, St Louis, USA). Dried blood spots in ®lter paper were analysed for whole blood TSH and serum T 4 using immunossay (Torresani & Scherz, 1986) . Urinary thiocyanate (SCN) was analyzed by a colorimetric method (Bowler, 1944) . Normal reference values are: UI, 50 ± 250 mgal; UIaSCN, b 3 mgamg (DeLange et al, 1983); serum Se, 65 ± 105 mgal; serum retinol, 0.35 ± 1.75 mmolal; whole blood TSH,`3.5 mUal; serum T 4 , 65 ± 165 nmolal.
Data which were normally distributed were expressed as means (s.d.) and were compared by Student's t-test. Parameters not normally distributed (UI, TSH, UIaSCN ratio) were expressed as medians with 95% con®dence intervals, and were compared by Mann ± Whitney tests. P-values were adjusted for multiple comparisons (Bonferroni correction). Multiple regression was used to test for associations.
Results
Baseline characteristics of the subjects are shown in Table  1 . There were no visible signs of acute protein-energy malnutrition in any of the subjects and the mean BMI of the children was near the 50th percentile for black children from the US (Must et al, 1991) . Median UI was 29 mgal; 20% and 90% of children had UI`20 mgal and`50 mgal, respectively, indicating moderate to severe iodine had values`30 mgal and 22% had values`6.5 mgal, the limit of sensitivity of our assay. Table 2 shows the changes in thyroid volume after receiving the iodized oil. Thyroid volume was decreased signi®cantly vs baseline at 10, 15, 30 and 50 weeks (P`0.001). At 15 and 50 weeks the mean percentage change in thyroid volume from baseline was 730.7% and 7 46.6%, respectively. There was a sharp reduction in goiter prevalence at 10,15, 30 and 50 weeks; at 50 weeks only ®ve children remained goitrous. Table 2 also shows the changes in TSH, T 4 and UI over the 50 weeks of followup. UI was signi®cantly increased above baseline at all time points (P`0.001). Median UI at 50 weeks was 97 mgal, just below the WHO cut-off value (100 mgal) for risk of IDD (WHOaUNICEFaICCIDD, 1994) . Although baseline and follow-up median TSH and mean serum T 4 were within the normal range, median TSH values at 5, 10, 15, 30 and 50 weeks were reduced signi®cantly (P`0.001) compared to baseline. Mean serum T 4 increased signi®cantly from baseline at 30 weeks (P`0.01).
To test for associations, multiple regression of percentage change in thyroid volume at 30 and 50 weeks on serum Se, serum retinol, UI, UIaSCN ratio and BMI was done. The regression of percentage change in thyroid volume at both 30 and 50 weeks on Se was highly signi®cant (P`0.005). Adding serum retinol, UI, BMI, or UIaSCN ratio did not improve the prediction at either time point. Regression of percentage decrease in TSH at 30 and 50 weeks on serum retinol, serum Se, UI, UIaSCN ratio and BMI was also done. The regression of percentage change on Se was signi®cant at 30 weeks (P`0.01) and at 50 weeks (P`0.5). Adding serum retinol, UI, BMI or UIaSCN ratio did not improve the prediction. Figure 1 shows the strong correlation (r 2 0.554) between baseline Se and percentage change in thyroid volume at 50 weeks after oral iodine. Because the correlation between baseline Se and percentage change in TSH was stronger at 30 weeks than at 50 weeks (although both were signi®cant), we have shown the correlation (r 2 0.467) at 30 weeks in Figure 2 .
Discussion
Selenocysteine has been identi®ed in the active center of the iodothyronine deiodinases, which regulate the formation and degradation of active thyroid hormone, 3,5,3 0 -triiodothyronine (T 3 ; Arthur et al, 1999) . In animals, Se Iodized oil and thyroid MB Zimmermann et al de®ciency lowers deiodinase activity (Beech et al, 1995) . In addition, Se de®ciency can reduce GPX activity and increase oxidative damage to the thyroid by hydrogen peroxide, which is produced in high amounts in the iodine-de®cient thyroid as a result of stimulation by TSH (Corvilain et al, 1993) . In a study in rats by Beckett et al, concurrent Se and iodine de®ciency produced a signi®cant increase in both thyroid weight and TSH and a decrease in thyroidal iodine when compared with either single Se or iodine de®ciency, suggesting that Se de®ciency can exacerbate the hypothyroidism observed in iodine de®ciency (Beckett et al, 1991) . In humans, cross-sectional studies have demonstrated that poor Se nutrition may be associated with impaired thyroid metabolism. In a study of children and young adults in iodine-de®cient areas of Malawi and Zaire, severe Se de®ciency was implicated in the high frequency of myxoedematous cretinism in Ubangi, Zaire (Thilly et al, 1993) . In Egypt, Samir found low levels of serum Se in subjects with multinodular goiter, as well as a weak correlation between serum Se and Serum T 4 and T 3 levels (Samir & el-Awady, 1998 ). Vanderpas et al studied Zairean schoolchildren and cretins in areas of endemic goiter and control areas and found that subjects in the area of endemic goiter had sharply lower serum Se and erythrocyte glutathione peroxidase (RBC-GPX) levels. Low RBC-GPX was associated with increased TSH levels. They concluded that combined iodine and Se de®ciency may be associated with the elevated frequency of endemic myxoedematous cretinism in Central Africa (Vanderpas et al, 1990) .
The severity of Se de®ciency in the children in this study is comparable to that described in the most Se de®cient areas of Zaire and China (Thilly et al, 1993; Moreno-Reyes et al, 1998) . Despite very low serum Se levels, the children in this study showed a rapid and sustained response to the oral iodized oil. There was a striking reduction in thyroid size and goiter prevalence during the 50 weeks of followup. Thyroid size was reduced by nearly half at 30 and 50 weeks and the goiter rate fell to near 10%. This reduction in goiter prevalence is more pronounced than those described by most previous authors (Bautista et al, 1982; Zitai, 1983; Eltom et al, 1985; Dunn, 1987; Benmiloud et al, 1994; Furne Âe et al, 1995) , but because of varying conditions in these studies (age of subjects, severity of iodine de®ciency, geographic location, ultrasound vs palpation for goiter grading, follow-up intervals), it is dif®cult to compare results. In an area of endemic goiter in the Sudan, 200 mg of iodine as iodized oil reduced goiter prevalence as measured by palpation by 60% at 1 y (Elnager et al, 1995) . In a study of goitrous adults in Zaire, 118 mg oral iodine reduced thyroid size as measured by a thyroid tracing method by 36% at 3 months and 52% at 1 y (Tonglet et al, 1992) . In the present study, we used thyroid ultrasonography, a more precise and objective method of measuring goiter size (Vitti et al, 1994) .
Among individual children the severity of Se de®ciency predicted the degree of response to iodized oil. As shown in Figures 1 and 2 , the most severely Se de®cient children showed a less vigorous response to the intervention. Both an anatomic indicator of response (percentage change in thyroid volume at 30 and 50 weeks) and a biochemical indicator of thyroid function (percentage decrease in TSH at 30 and 50 weeks) were signi®cantly correlated with serum Se at baseline. Thus, although more severe Se de®ciency may partially blunt the thyroid response to iodine supplementation, the use of oral iodized oil is a safe and effective method for iodine repletion in goitrous children who are Se de®cient.
The present study describes the in¯uence of Se status on the response to iodine supplementation in iodine de®cient children. However, Se may be only one of many nutritional in¯uences that in¯uence the pathogenesis of IDD in iodinede®cient areas. We have recently shown that concurrent iron de®ciency impairs the response of iodine-de®cient, goitrous children to oral iodized oil. In the iron de®cient children in that study, Se status was not correlated with response to iodine repletion (Zimmermann et al, 2000) . In the present study, all of the children had Hb b 120 mgal. Food goitrogens (Gaitan, 1990) and vitamin A de®ciency (Wolde-Gebriel et al, 1993) may also adversely affect thyroid metabolism. Although many of the children in this study had low levels of serum retinol and very low UIaSCN ratios, multiple regression indicated that serum Se was the only signi®cant determinant of their response to oral iodized oil.
A limitation of the study design was the use of a single baseline measurement of serum Se as the only measure of Se status in the children. It would have been preferable to have repeated measurements of serum Se during the study andaor functional measures of Se status such as RBC-GPX (Foster & Sumar, 1997) . The chiefs and the families of the children involved were reluctant to have blood drawn from the children and so we were unable to do repeated venipuncture. However, in this region, dietary supply of Se probably varies only minimally throughout the year due to the consumption of a fairly monotonous diet consisting mainly of cassava and rice.
In these goitrous, Se-de®cient children, there were no apparent adverse effects from the 200 mg oral dose of iodine. None of the children showed signs of iodine induced hyper-or hypothyroidism or other adverse effects. Studies in Zaire have shown that correcting Se de®ciency before improving iodine status of hypothyroid iodine-and Se-de®cient subjects can aggravate hypothyroidism (Contempre et al, 1991) . Therefore, it is important to correct iodine de®ciency ®rst and, based on the results of this study, the use of iodized oil appears to be safe and effective in children who are both iodine and Se de®cient.
